Canadian Pharmaceuticals & Biotech Price disconnect

Results

2 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

3 companies

Green Thumb Industries

Market Cap: CA$2.1b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

GTII

CA$9.60

-4.9%

-2.3%

Knight Therapeutics

Market Cap: CA$958.2m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

GUD

CA$9.76

-0.8%

54.2%

BioSyent

Market Cap: CA$171.6m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

CA$15.00

1.7%

31.6%